drugset / Trial / NCT00829816
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-04
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latrepirdine | Small molecule | 20 mg | Oral |